Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.
65% of all big pharma revenues now come from dealmaking, confirming a need for robust inorganic growth and value creation strategies.
Iulius Dan Plaveti has taken over as Chairman of the Board and CEO of Hidroelectrica starting 10 June 2026, with his mandate running until 7 November 2027.
Visual Fan has completed the energisation phase of its Full EPC BESS project in Teiuș, featuring a storage capacity of 120 MWh.
The TechAngels Board has appointed Ana Maria Andronic as President for a mandate lasting until next year's internal elections.
Romanian entrepreneur Iulian Stanciu has announced the sale of his stake in eMAG Group to Prosus, 17 years after taking over the company and 14 years after signing the partnership with Naspers (Prosus).
Romanian consumers are becoming increasingly pessimistic about the country's economic and political outlook while continuing to prioritise spending and aggressively seek value, according to the latest Consumer Sentiment Survey by Boston Consulting Group (BCG).